Home
/ Ipsen
/ Competitors

Ipsen Competitors and Similar CompaniesClear all

Ipsen's competitors and similar companies include Zentiva, Idorsia and Genentech.

	Ipsen Ipsen is a biopharmaceutical company.	Zentiva Zentiva is a company that develops and manufactures generic medicines.	Idorsia Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
Founding Date	Founding Date 1929	Founding Date 2003	Founding Date 2017	Founding Date 1976
Type	Type Public	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more	Locations CZ HQ Tallinn, EE Paris, FR Mumbai, IN Milano, IT Milano, IT Rīga, LV see more	Locations Allschwil, CH HQ Shanghai, CN Lörrach, DE Chiyoda City, JP	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more
Employees	Employees 5,358	Employees 3,4721% increase	Employees 8007% increase	Employees 18,077
Financial
Revenue (est.)	Revenue (est.) €3.7b (FY, 2025)	Revenue (est.) Kč2.3b (FY, 2021)	Revenue (est.) CHF220.6m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods €659.1m (FY, 2025)	Cost of goods Kč807.2m (FY, 2021)	Cost of goods CHF20.9m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit €3.3b (FY, 2025)	Gross profit Kč1.5b (FY, 2021)	Gross profit CHF214.3m (FY, 2025)	Gross profit N/A
Net income	Net income €445.1m (FY, 2025)	Net income (Kč831.2m) (FY, 2021)	Net income (CHF111.7m) (FY, 2025)	Net income N/A